Single-tablet regimens for HIV: Difference between revisions
From IDWiki
(Imported from text file) |
(Redirected page to HIV medications) Tag: New redirect |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
#REDIRECT [[HIV medications#Single-Tablet Regimens]] |
|||
= Single-tablet regimens = |
|||
See also [HIV treatment](HIV treatment.md) |
|||
{| |
|||
! Brand name |
|||
! NRTIs |
|||
! Non-NRTI |
|||
! Notes |
|||
|- |
|||
| Triumeq |
|||
| abacavir / lamivudine |
|||
| dolutegravir (INI) |
|||
| Highest barrier to resistance. Need to test for HLA-B5701 allele before starting. Avoid in hepatitis B coinfection. |
|||
|- |
|||
| Atripla |
|||
| tenofovir disoproxil / emtricitabine |
|||
| efavirenz |
|||
| Older regimen. Neuropsychiatric symptoms, possibly including suicide. |
|||
|- |
|||
| Complera |
|||
| tenofovir disoproxil / emtricitabine |
|||
| rilpivirine |
|||
| Avoid with viral loads (>100,000) or low CD4 (<200). Pill must be taken with food (>400kcal) and without PPIs. |
|||
|- |
|||
| Stribild |
|||
| tenofovir disoproxil / emtricitabine |
|||
| elvitegravir/cobicistat (INI) |
|||
| Includes a P450 inhibitor to boost elvitegravir levels, with resultant drug-drug interactions. Avoid if CrCl <70. |
|||
|- |
|||
| Biktarvy |
|||
| FTC/TAF |
|||
| BIC |
|||
| |
|||
|} |
|||
* |
|||
* |
|||
Latest revision as of 22:23, 4 February 2020
Redirect to:
